Cleared Traditional

K874252 - KREDA DISC

K874252 is an FDA 510(k) clearance for KREDA DISC, manufactured by Richmond Products, Inc.. The device is a Class 1 Ophthalmic device with product code HOQ cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K874252 · Richmond Products, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1988
Decision
100d
Days
Class 1
Risk

K874252 is an FDA 510(k) clearance for the KREDA DISC. Classified as Grid, Amsler (product code HOQ), Class I - General Controls.

Submitted by Richmond Products, Inc. (Boca Raton, US). The FDA issued a Cleared decision on January 27, 1988 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1330 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Richmond Products, Inc. devices

FDA 510(k) Submission Details - K874252

510(k) Number K874252 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 1987
Decision Date January 27, 1988
Days to Decision 100 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 110d · This submission: 100d
Pathway characteristics
Predicate-based equivalence.

HOQ Device Classification - Class 1, General Controls

Product Code HOQ Grid, Amsler
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.1330
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.